The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Programmatic real estate joint venture formation
Represented real estate firm in connection with the formation of a programmatic real estate joint venture with a national equity participant.  The more
Construction counsel for $500 million waste water and tunnel project in Northeast
Represented the public owner and were part of its project team from day one.  In particular, the firm developed contract documents for the deep more
Medical malpractice
Represented a widower after his wife died due to healthcare negligence.  The case resulted in one of the largest medical malpractice settlements ever more
Environmental and redevelopment issues for Georgia-based utility
Assisted major utility in dealing with environmental and redevelopment issues related to legacy energy generation sites throughout Georgia and more